IL18 and non-small cell lung carcinoma: XIST knockdown partially inhibited the development of NSCLC by targeting the miR-335/SOD2 signalling pathway and promoting downstream ROS generation, which induced pyroptotic cell death through activation of the NLRP3 inflammasome and increased levels of cleaved caspase-1, mature IL-1β and IL-18.